Grant

First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders (U01 Clinical Trial Required)

CountryUnited States
Deadline2027-10-15 (327 days left)
Published2024-11-26
SectorsHealth & life sciences
SourceGrants.gov (US)

Summary

Funding opportunity PAR-25-180. CFDA: 93.242

The buyer, the value, the full description and the link to the official notice are available with a free account.